Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence
The recombinant zoster vaccine (RZV) was licensed in the US for prevention of herpes zoster (HZ) in 2017. We conducted a literature search (January 1, 2017–August 1, 2023) using PubMed, Embase, and Scopus to consolidate the real-world evidence related to RZV. Overall, RZV effectiveness against HZ wa...
Sparad:
| Huvudupphov: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Taylor & Francis Group
2023-12-01
|
| Serie: | Human Vaccines & Immunotherapeutics |
| Ämnen: | |
| Länkar: | https://www.tandfonline.com/doi/10.1080/21645515.2023.2263979 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|